Join to View Full Profile
9609 Medical Center DriveBuilding 9609 MSC 9760Bethesda, MD 20892
Phone+1 240-781-3300
Dr. Sharpless is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 2000
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
University of North Carolina at Chapel Hill School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 2002 - 2018
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- The Hurria Older PatiEnts (HOPE) With Breast Cancer Study Start of enrollment: 2011 Sep 09
- Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy Start of enrollment: 2012 Oct 01
- The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Bridging the Gap in Cancer Clinical Trial Funding.Yara Abdou, Norman E Sharpless
Journal of Clinical Oncology. 2024-11-20 - 4 citationsmiR-29 is an important driver of aging-related phenotypes.Vijay Swahari, Ayumi Nakamura, Emilie Hollville, Yu-Han Hung, Matt Kanke
Communications Biology. 2024-08-27 - 5 citationsAuthor Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.George P Souroullas, William R Jeck, Joel S Parker, Jeremy M Simon, Jie-Yu Liu
Nature Medicine. 2024-06-01
Press Mentions
Karius Secures $100M to Expand Non-Invasive Pathogen Blood TestFebruary 5th, 2024- Katie Couric’s Breast Cancer Diagnosis Highlights the Importance of ScreeningsOctober 5th, 2022
- Americans Are Reckoning with Repercussions of Missed Cancer ScreeningsJune 13th, 2022
- Join now to see all
Grant Support
- In Vivo Murine Models Of Metastasis For Therapeutic TestingNational Cancer Institute2012
- UNC Oncology Clinical Translational Research Training ProgramNational Cancer Institute2011
- Murine &Human In Vivo Models Of Melanoma FormationNational Institute Of Environmental Health Sciences2007–2011
- The Role Of P16INK4A In Mammalian AgingNational Institute On Aging2004–2011
- Melanoma In P16INK4A And P19ARF Deficient MiceNational Cancer Institute2002–2006
- Melanoma In P16INK4A And P19ARF Deficient MiceNational Cancer Institute2002
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
